Evidence map›Paper›PMID 39506064›Full record

ReviewActa pharmacologica Sinica2025

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.

Zheng-Jie Chia, Hirushi Kumarapperuma, Ruizhi Zhang, Peter J Little, Danielle Kamato

Abstract readReview
In one paragraph

Review in Acta pharmacologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zheng-Jie Chia *Institute for Biomedicine and Glycomics, Griffith University, Nathan, QLD, Australia.
Hirushi KumarapperumaInstitute for Biomedicine and Glycomics, Griffith University, Nathan, QLD, Australia.
Ruizhi ZhangInstitute for Biomedicine and Glycomics, Griffith University, Nathan, QLD, Australia.
Peter J LittleSchool of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia.
Danielle Kamato *Institute for Biomedicine and Glycomics, Griffith University, Nathan, QLD, Australia. d.kamato@griffith.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Smad transcription factors are well known for their role at the core of transforming growth factor-β (TGF-β) signalling. However, recent evidence shows that the Smad transcription factors play a vital role downstream of other classes of receptors including G protein-coupled receptors (GPCR). The versatility of Smad transcription factors originated from the two regions that can be differently activated by the TGF-β receptor superfamily or through the recruitment of intracellular kinases stimulated by other receptors classes such as GPCRs. The classic GPCR signalling cascade is further expanded to conditional adoption of the Smad transcription factor under the stimulation of Akt, demonstrating the unique involvement of the Smad transcription factor in GPCR signalling pathways in disease environments. In this review, we provide a summary of the signalling pathways of the Smad transcription factors as an important downstream mediator of GPCRs, presenting exciting opportunities for discovering new therapeutic targets for diseases.

Indexed as

Receptors, G-Protein-CoupledSignal TransductionSmad ProteinsAnimalsHumansReceptors, G-Protein-CoupledSmad ProteinsAktGPCR signallingphospho-SmadSmadtransactivation dependenttransforming growth factor-beta receptor

Identifiers

PMID39506064
PMCPMC11950520

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.